Home
Conditions
Adenocarcinoma

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

5,051 public trials 1,181 recruiting studies

Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Completed

Role of Perfluorobutane in Lesion Detection, Targeting and Response Assessment for Ablation of HCC

NCT05068076

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations: Institute of Liver & Biliary Sciences New Delhi, National Capital Territory of Delhi, India

View Trial Details

Completed

Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)

NCT01772004

Conditions: Adenocarcinoma, Adnexal Diseases, Adrenal Cortex Diseases, +62 more
Locations: Cancer Treatment Centers of America - Western Regional Medical Center Goodyear, Arizona, United States

Scottsdale Healthcare Corporation Scottsdale, Arizona, United States

Pinnacle Oncology Hematology Scottsdale, Arizona, United States

Highlands Oncology Group Rogers, Arkansas, United States

View all 74 locations

View Trial Details

Completed

Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors

NCT02259725

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +25 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

USC Norris Comprehensive Cancer Center Los Angeles, California, United States

Hoag Memorial Hospital Presbyterian Newport Beach, California, United States

USC Norris Oncology Hematology-Newport Beach Newport Beach, California, United States

View Trial Details

Completed

PEN-221 in Somatostatin Receptor 2 Expressing Advanced Cancers Including Neuroendocrine and Small Cell Lung Cancers

NCT02936323

Conditions: Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +18 more
Locations: Florida Cancer Specialists South Fort Myers, Florida, United States

Florida Cancer Specialists North St. Petersburg, Florida, United States

Massachusetts General Hospital Boston, Massachusetts, United States

Boston Medical Center Boston, Massachusetts, United States

View all 13 locations

View Trial Details

Completed

REGISTRY OF COMPLETE RESPONSES TO SUNITINIB IN SPANISH PATIENTS WITH METASTATIC RENAL CELL CARCINOMA

NCT03916458

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
Locations: Hospital Duran i Reynals L'Hospitalet de Llobregat, Barcelona, Spain

Hospital San Juan de Dios Manresa, Barcelona, Spain

Hospital Parc Taulí de Sabadell Sabadell, Barcelona, Spain

Hospital Universitario Mutua Terrassa Terrassa, Barcelona, Spain

View all 31 locations

View Trial Details

Completed

Routine Lymphadenectomy for Intrahepatic Cholangiocarcinoma

NCT03796819

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +9 more
Locations: The First Affiliated Hospital of Xi'an Jiaotong University Xi'an, Shaanxi, China

View Trial Details

Completed

Predictive MRI Metrics for Tumor Aggressiveness in Papillary Thyroid Cancer

NCT02178345

Conditions: Adenocarcinoma, Adenocarcinoma, Papillary, Carcinoma, +11 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Contrast-enhanced Ultrasound With Perfluorobutane and Sulfur Hexafluoride for Hepatocellular Carcinoma

NCT04847726

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Seoul National University Hospital Seoul, Jongno-gu, South Korea

View Trial Details

Completed

Phase 1/2 Study of Tivozanib in Combination With Nivolumab in Subjects With RCC

NCT03136627

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
Locations: Bordeaux Hospital University Center (CHU) Bordeaux, France

Center Léon Bérard Lyon, France

Centre Paul Strauss Strasbourg, France

Institut Gustave Roussy Villejuif, France

View Trial Details

Completed

Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC)

NCT03111732

Conditions: Adenocarcinoma, Bile Duct Cancer, Bile Duct Diseases, +17 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Adenocarcinoma

Adenocarcinoma trial results

Related conditions